top headlines
Xeltis has passed the halfway enrolment mark in its US [...]
Active Care Group has announced plans to develop a new [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
Vect-Horus has entered a research collaboration and exclusive licence option [...]
The Fleming Initiative has selected Amazon Web Services (AWS) to [...]
A peer-reviewed study has demonstrated that Cumulus Neuroscience’s NeuLogiq platform [...]
Lonza has acquired the rights to Nona Biosciences’ transferrin receptor [...]
Telix Pharmaceuticals has received FDA agreement on the protocol and [...]
SERB has completed its €115 million licensing agreement with Hansa [...]
